Skip to main content
SpringerLink
Log in

Atherosclerotic Peripheral Artery Disease: Clinical Management

  • Reference work entry
  • First Online:
PanVascular Medicine

  • 171 Accesses

Abstract

The diagnosis of atherosclerotic peripheral arterial disease (PAD) is often overlooked because the vast majority of patients are either asymptomatic or have atypical symptoms (Anderson JL et al., Circulation 127:1425–1443, 2013; Hirsch AT et al., JAMA 286(11):1317–1324, 2001a). Furthermore, even when atherosclerotic PAD is appropriately diagnosed, these patients are still consistently undertreated (Hirsch AT et al., Vasc Med 6(Suppl 3):9–12, 2001b). In an era when there remains a discordance between the implications of a disease process and the attention that is given to it, familiarity with the diagnostic modalities and treatment strategies cannot be underemphasized. The following chapter will be a comprehensive review of both the diagnosis and medical management of atherosclerotic PAD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aboyans V, Criqui MH, Abraham P, Allison MA, Creager MA, Diehm C, Fowkes FG, Hiatt WR, Jonsson B, Lacroix P, Marin B, McDermott MM, Norgren L, Pande RL, Preux PM, Stoffers HE, Treat-Jacobson D, American Heart Association Council on Peripheral Vascular Disease, Council on Epidemiology and Prevention, Council on Clinical Cardiology, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular Surgery and Anesthesia (2012) Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126(24):2890–2909

    Article  PubMed  Google Scholar 

  • Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen W (2013) Management of patients with peripheral artery disease (complication of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127:1425–1443

    Article  PubMed  Google Scholar 

  • Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71

    Article  Google Scholar 

  • Beckman JA, Jaff MR, Creager MA (2006) The United States preventive services task force recommendation statement on screening for peripheral arterial disease: more harm than benefit? Circulation 114:861–866

    Article  PubMed  Google Scholar 

  • Bhatt DK, Fox KA, Werner Hack CB, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Flather MD, Haffner SM, Hamm CW, Hankey GJ, Johnston SC, Mak K, Mas J, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Brennan DM, Fabry-Ribaudo L, Booth J, Topol EJ (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706–1717

    Article  CAS  PubMed  Google Scholar 

  • CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348(9038):1329–1339

    Article  Google Scholar 

  • Chi Y, Lavie CJ, Milani RV, White CJ (2008) Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc Health Risk Manag 4(6):1197–1203

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Creager MC, Beckman JA, Loscalzo J (2013) Vascular medicine. A companion to Braunwald’s heart disease, 2nd edn. Saunders, Philadelphia

    Google Scholar 

  • Criqui MH, Denenberg JO, Bird CE, Fronek A, Klauber MR, Langer RD (1996) The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med 1(1):65–71

    CAS  PubMed  Google Scholar 

  • Darling RC, Raines JK, Brener BJ, Austen WG (1972) Quantitative segmental pulse volume recorder: a clinical tool. Surgery 72(6):873–877

    CAS  PubMed  Google Scholar 

  • Dawson DL, Cutler BS, Meissner MH, Strandness DE Jr (1998) Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blinded trial. Circulation 98(7):678–686

    Article  CAS  PubMed  Google Scholar 

  • de Groot E, Jukema JW, Montauban van Swijndregt AD, Zwinderman AH, Ackerstaff RG, van der Steen AF, Bom N, Lie KI, Bruschke AV (1998) B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J Am Coll Cardiol 31:1561–1567

    Article  PubMed  Google Scholar 

  • Diehm C, Allenberg JR, Pittrow D, Mahn M, Tepohl G, Haberl RL, Darius H, Burghaus I, Trampisch HJ, German Epidemiological Trial on Ankle Brachial Index Study Group (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120:2053–2061

    Article  PubMed  Google Scholar 

  • Dieter RS, Dieter RA, Dieter RA (2009) Peripheral arterial disease. McGraw-Hill, New York

    Google Scholar 

  • Dieter RS, Dieter RA, Dieter RA (2014) Endovascular interventions. A case-based approach. Springer, New York

    Book  Google Scholar 

  • Erez G, Leitersdorf E (2007) The rationale for using HMG-CoA reductase inhibitors (“statins”) in peripheral arterial disease. Eur J Vasc Endovasc Surg 33(2):192–201

    Article  CAS  PubMed  Google Scholar 

  • Faulkner KW, House AK, Castleden WM (1983) The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease. Med J Aust 1(5):217–219

    CAS  PubMed  Google Scholar 

  • Feringa HH, van Waning VH, Bax JJ, Elhendy A, Boersma E, Schouten O, Galal W, Vidakovic RV, Tangelder MJ, Poldermans D (2006) Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 47(6):1182–1187

    Article  PubMed  Google Scholar 

  • Freund KM, Belanger AJ, D’Agostino RB, Kannel WB (1993) The health risks of smoking. The framingham study: 34 years of follow-up. Ann Epidemiol 3:417–424

    Article  CAS  PubMed  Google Scholar 

  • Fuster VF, Alexander RW, O’Rouke RA, Robert R, King SB III, Wellens HJ (2001) Hurst’s the heart. McGraw-Hill, New York

    Google Scholar 

  • Gardner AW, Poehlman ET (1995) Exercise rehabilitation programs for the treatment of claudication pain: a meta-analysis. JAMA 274:975–980

    Article  CAS  PubMed  Google Scholar 

  • Gargiulo G, Giugliano G, Esposito G (2012) Use of statins in lower extremity disease: a review. BMC Surg 12(Suppl 1):S15

    Article  PubMed  PubMed Central  Google Scholar 

  • Gerhard-Herman M, Gardin JM, Jaff M, Mohler E, Roman M, Naqvi TZ (2006) Guidelines for noninvasive vascular laboratory testing: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 19:955–972

    Article  PubMed  Google Scholar 

  • Hammer A, Steiner S (2013) Gene therapy for therapeutic angiogenesis in peripheral arterial disease – a systematic review and meta-analysis of randomized, controlled trials. Vasa 42(5):331–339

    Article  PubMed  Google Scholar 

  • Heart Protection Study Collaborative Group (2002) MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360(9326):7–22

    Article  Google Scholar 

  • Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR (2001a) Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286(11):1317–1324

    Article  CAS  PubMed  Google Scholar 

  • Hirsch AT, Hiatt WR, PARTNERS Steering Committee (2001b) PAD awareness, risk and treatment: new resources for survival – the USA PARTNERS program. Vasc Med 6(Suppl 3):9–12

    Article  CAS  PubMed  Google Scholar 

  • Hoogeveen EK, Mackaay AJ, Beks PJ, Kostense PJ, Dekker JM, Heine RJ, Nijpels G, Rauwerda JA, Stehouwer CD (2008) Evaluation of the one-minute exercise test to detect peripheral arterial disease. Eur J Clin Invest 38(5):290–295

    Article  CAS  PubMed  Google Scholar 

  • Hummel BW, Hummel BA, Mowbry A, Maixner W, Barnes RW (1978) Reactive hyperemia vs. treadmill exercise testing in arterial disease. Arch Surg 113:95–98

    Article  CAS  PubMed  Google Scholar 

  • Jonason T, Bergstrom R (1987) Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 221:253–260

    Article  CAS  PubMed  Google Scholar 

  • Leng GC, Fowkes FG (1992) The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 45(10):1101–1109

    Article  CAS  PubMed  Google Scholar 

  • Marso SP, Hiatt WR (2006) Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol 47:921–929

    Article  PubMed  Google Scholar 

  • McPhail IR, Spittell PC, Weston SA, Bailey KR (2001) Intermittent claudication: an objective office-based assessment. J Am Coll Cardiol 37(5):1831–1835

    Article  Google Scholar 

  • Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K (2009) Efficacy of pharmacotherapies for short-term smoking abstinence: a systematic review and meta-analysis. Harm Reduct J 6:25

    Article  PubMed  PubMed Central  Google Scholar 

  • Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS (2009) Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies. Eur J Vasc Endovasc Surg 38(4):463–474

    Article  CAS  PubMed  Google Scholar 

  • Money SR, Herd JA, Isaacsohn JL, Davison M, Cutler B, Heckman J, Forbes WP (1998) Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 27(2):267–274

    Article  CAS  PubMed  Google Scholar 

  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, TASC II Working Group (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:S5–S67

    Article  PubMed  Google Scholar 

  • Ouriel K, McDonnell AE, Metz CE, Zarins CK (1982) Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 91(6):686–693

    CAS  PubMed  Google Scholar 

  • Overlack A, Adamczak M, Bachmann W, Bonner G, Bretzel RG, Derichs R, Krone W, Lederle RM, Reimann HF, Zschiedrich H (1994) ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group. Am J Med 97(2):126–134

    Article  CAS  PubMed  Google Scholar 

  • Quick CR, Cotton LT (1982) The measured effect of stopping smoking on intermittent claudication. Br J Surg 69(Suppl):S24–S26

    Article  PubMed  Google Scholar 

  • Radack K, Deck C (1991) Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 151(9):1769–1776

    Article  CAS  PubMed  Google Scholar 

  • Robless P, Michailidis DP, Stansby GP (2008) Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev 1, CD003748

    Google Scholar 

  • Rumwell C, McPharlin M (2004) Vascular technology, 3rd edn. Davies, Pasadena

    Google Scholar 

  • Rutherford RB, Lowenstein DH, Klein MF (1979) Combining segmental systolic pressures and plethysmography to diagnose arterial occlusive disease of the legs. Am J Surg 138(2):211–218

    Article  CAS  PubMed  Google Scholar 

  • Rutherford RB, Baker DJ, Ernst CE, Johnston KW, Porter JM, Ahn S, Jones DN (1997) Recommended standards for reports dealing with lower extremity ischemia: a revised version. J Vasc Surg 26(3):517–538

    Article  CAS  PubMed  Google Scholar 

  • Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA (2012) Pentoxifylline for intermittent claudication. Cochrane Database Syst Rev 1, CD005262

    PubMed  Google Scholar 

  • Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT (2002) Exercise training for claudication. N Engl J Med 347:1941–1951

    Article  PubMed  Google Scholar 

  • The AIM-HIGH Investigators (2011) Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med 365:2255–2267

    Article  Google Scholar 

  • The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators (2000) Effects of angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145–153

    Article  Google Scholar 

  • UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853

    Article  Google Scholar 

  • United States Preventive Services Task Force (2005) Recommendation statement: screening for peripheral arterial disease. Agency for Healthcare Research and Quality, Washington, DC, pp 1–8

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Associate Professor of Medicine, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL, 60153, USA

    Robert S. Dieter

  2. Hines VA Medical Center, Hines, IL, USA

    Robert S. Dieter

  3. Stritch School of Medicine, Loyola University Medical Center, Cardiology, Maywood, IL, USA

    Tariq Salman & Conner O’Keefe

Authors
  1. Tariq Salman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Conner O’Keefe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert S. Dieter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert S. Dieter .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Disease Department of Internal Medicine, Health Care Center Bitterfeld, Bitterfeld-Wolfen, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Salman, T., O’Keefe, C., Dieter, R.S. (2015). Atherosclerotic Peripheral Artery Disease: Clinical Management. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_111

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37078-6_111

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37077-9

  • Online ISBN: 978-3-642-37078-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation